LINH TANG: Open Payments
NPI 1447876560 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$978 in 50 payments from 17 companies in 2025. Trend: 2023 $1,169 · 2024 $1,635 · 2025 $978
Food & beverage: $978
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 11 | $271 |
| Bayer Healthcare Pharmaceuticals Inc. | 14 | $158 |
| AstraZeneca Pharmaceuticals LP | 4 | $146 |
| Amgen Inc. | 4 | $62 |
| Novo Nordisk Inc | 3 | $47 |
| Astellas Pharma US Inc | 2 | $43 |
| Merck Sharp & Dohme LLC | 2 | $33 |
| Lilly USA, LLC | 1 | $28 |
| Renalytix AI, Inc. | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $24 |
Products named: Kerendia, AIRSUPRA, OTEZLA, FARXIGA, Veozah, MOUNJARO, Livdelzi, KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT.
Industry payments across AZ — which companies pay providers there.
